-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE: FDA APPROVES UPDATE TO SKYRIZI U.S. PRESCRIBING INFORMATION ALLOWING CLINICAL JUDGMENT ON TUBERCULOSIS TESTING ACROSS ALL INDICATIONS

Reuters·10/23/2026 19:33:58

Please log in to view news